Vertaling van "for veterinary use – cvmp " (Nederlands → Frans) :

Via zijn afgevaardigden binnen de werkgroep voor de evaluatie van immunologische producten (Immunologicals Working Party - IWP) en binnen het Comité voor geneesmiddelen voor diergeneeskundig gebruik (Committee for Medicinal Products for Veterinary Use – CVMP) heeft het FAGG significant bijgedragen aan het uitwerken van 3 belangrijke documenten over vaccins voor diergeneeskundig gebruik.
Via zijn afgevaardigden binnen de werkgroep voor de evaluatie van immunologische producten (Immunologicals Working Party - IWP) en binnen het Comité voor geneesmiddelen voor diergeneeskundig gebruik (Committee for Medicinal Products for Veterinary Use – CVMP) heeft het FAGG significant bijgedragen aan het uitwerken van 3 belangrijke documenten over vaccins voor diergeneeskundig gebruik.

De Belgische vertegenwoordigers in het Committee for Medicinal Products for Veterinary Use (CVMP) hebben op een totaal van 56 producten, 20 maal het (co-)rapporteurship voor immunologische producten op zich genomen.
Au total, les représentants belges au Committee for Medicinal Products for Veterinary Use (CVMP) ont été/sont, sur un total de 56 produits, rapporteurs ou co-rapporteurs pour des médicaments immunologiques à 20 reprises.

-- Further guidance on interpretation of the data from guideline CVMP-VICH GL27 guidance on pre-approval information for registration of new veterinary medicinal products for food producing animals with respect to antimicrobial resistance (CVMP/VICH/644/01)
-- Further guidance on interpretation of the data from guideline CVMP-VICH GL27, guidance on pre-approval information for registration of new veterinary medicinal products for food producing animals with respect to antimicrobial resistance (CVMP/VICH/644/01)

EMEA/CVMP/413/99-Rev 1 VEDDRA List of clinical terms for reporting adverse reactions in animals to veterinary medicines Wordt herzien op basis van het PhVWP-V-werkprogramma voor 2005 (VEEDRA-subgroep komt op 5 mei 2005 bijeen; wordt op 5 juli 2005 door de PhVWP-V en op 5 september 2005 door het CVMP aangenomen)
EMEA/CVMP/413/99-Rev 1 VEDDRA List of clinical terms for reporting adverse reactions in animals to veterinary medicines À réviser selon le programme de travail du PhVWP-V pour 2005 (réunion du sous-groupe VEDDRA en mai 2005; adoption par le PhVWP en juillet 05 et le par le CVMP en septembre 05)

Het CVMP heeft zijn standpuntnota met betrekking tot de beschikbaarheid van producten voor minder belangrijke indicaties en diersoorten (Position paper regarding availability of products for minor uses and minor species - EMEA/CVMP/477/03/final) vastgesteld, waarin uitvoerig de strategie wordt beschreven die gevolgd moet worden om een grotere beschikbaarheid van geneesmiddelen in de veterinaire sector te bewerkstelligen.
Le CVMP a adopté son «Document de position relatif à la disponibilité des médicaments destinés à des utilisations mineures et à des espèces mineures« (EMEA/CVMP/477/03/final) qui détaille la stratégie à adopter pour progresser dans la voie d'une plus grande disponibilité des médicaments dans le secteur vétérinaire.

CVMP Committee for Medicinal Products for Veterinay Use
Marquage que les entreprises doivent mettre sur les produits

The FAMHP intends to significantly increase its involvement in the lifecycle of immunological medicines for veterinary use by providing scientific advice, evaluating applications for clinical trials in Belgium, adopting (co-)rapporteurships for CP, MRP and DCP for MA of vaccines for veterinary use and developing pharmacovigilance and inspection activities.
The FAMHP intends to significantly increase its involvement in the lifecycle of immunological medicines for veterinary use by providing scientific advice, evaluating applications for clinical trials in Belgium, adopting (co-)rapporteurships for CP, MRP and DCP for MA of vaccines for veterinary use and developing pharmacovigilance and inspection activities.

1974 on the opening, transfer and merger of retail pharmacies Royal decree of 9 July 1984 on the provision of information and advertising relating to medicines Royal decree of 11 January 1993 determining the conditions under which medicines for human use may be supplied in sample form Royal decree of 7 April 1995 on the provision of information and advertising relating to medicines for human use Royal decree of 15 July 1997 on active implantable medical devices, transposing Directive 90/385 EEC (AIMD) Royal decree of 19 December 1997 on the control and analysis of the raw materials used by dispensing chemists Royal decree of 18 March 1999 on medical devices, transposing Directive 93/42/EEC of 14 June 1993 (MDD) Royal decree of 11 July 2003 determining the conditions under which medicines for veterinary use may be supplied in sample form Law of 16 December 2004 modifying the regulations on combating abuses in the promotion of medicines Royal decree of 10 June 2006 establishing the report point referred to in Article 10, § 5, of the law of 25 March 1964 on medicines Royal decree of 23 November 2006 implementing Article 10, § 3, of the law of 25 March 1964 on medicines Royal decree of 25 February 2007 recognising the institutions referred to in Article 10 § 3 of the law of 25 March 1964 on medicines
1974 on the opening, transfer and merger of retail pharmacies Royal decree of 9 July 1984 on the provision of information and advertising relating to medicines Royal decree of 11 January 1993 determining the conditions under which medicines for human use may be supplied in sample form Royal decree of 7 April 1995 on the provision of information and advertising relating to medicines for human use Royal decree of 15 July 1997 on active implantable medical devices, transposing Directive 90/385 EEC (AIMD) Royal decree of 19 December 1997 on the control and analysis of the raw materials used by dispensing chemists Royal decree of 18 March 1999 on medical devices, transposing Directive 93/42/EEC of 14 June 1993 (MDD) Royal decree of 11 July 2003 determining the conditions under which medicines for veterinary use may be supplied in sample form Law of 16 December 2004 modifying the regulations on combating abuses in the promotion of medicines Royal decree of 10 June 2006 establishing the report point referred to in Article 10, § 5, of the law of 25 March 1964 on medicines Royal decree of 23 November 2006 implementing Article 10, § 3, of the law of 25 March 1964 on medicines Royal decree of 25 February 2007 recognising the institutions referred to in Article 10 § 3 of the law of 25 March 1964 on medicines

clinical trials with veterinary medicines and medical devices for veterinary use ●● Reduction of the backlogs for veterinary
clinical trials with veterinary medicines and medical devices for veterinary use ●● Reduction of the backlogs for veterinary

Advisory commission which is consulted e.g. in cases of non-availability of medicines Commission for the approval of institutions assigning preliminary approvals for scientific events Commission for the establishment of retail pharmacies and chambers of appeal (Frenchspeaking chamber and Dutch-speaking chamber) Commission for the recognition of pharmacists-clinical biologists Commission for the supervision of advertising for medicines for human use Evaluation commission for active implantable medical devices Evaluation commission for homeopathic medicines Evaluation commission for medical devices Evaluation commission for medicines for human use Evaluation commission for medicines for veterinary use Evaluation commission for traditional herbal medicines Pharmacopoeia commission
Advisory commission which is consulted e.g. in cases of non-availability of medicines Commission for the approval of institutions assigning preliminary approvals for scientific events Commission for the establishment of retail pharmacies and chambers of appeal (Frenchspeaking chamber and Dutch-speaking chamber) Commission for the recognition of pharmacists-clinical biologists Commission for the supervision of advertising for medicines for human use Evaluation commission for active implantable medical devices Evaluation commission for homeopathic medicines Evaluation commission for medical devices Evaluation commission for medicines for human use Evaluation commission for medicines for veterinary use Evaluation commission for traditional herbal medicines Pharmacopoeia commission